Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Analytical Method Development: SOP for LOD and LOQ Determination – V 2.0

Posted on By

Analytical Method Development: SOP for LOD and LOQ Determination – V 2.0

Standard Operating Procedure for Determination of LOD and LOQ in Analytical Methods


Department Analytical Method Development
SOP No. SOP/AMD/202/2025
Supersedes SOP/AMD/202/2022
Page No. Page 1 of 12
Issue Date 21/05/2025
Effective Date 23/05/2025
Review Date 21/05/2026

1. Purpose

This SOP outlines the procedure to determine the Limit of Detection (LOD) and Limit of Quantification (LOQ) of analytical methods developed in the Analytical Method Development department. The goal is to

ensure methods meet sensitivity and quantification requirements as per ICH Q2(R1).

2. Scope

This SOP applies to all newly developed and validated methods in the Analytical Method Development laboratory for APIs and formulated products, where LOD and LOQ assessments are required.

3. Responsibilities

  • Analytical Scientist: Prepares calibration curve data and calculates LOD/LOQ.
  • Group Leader: Reviews the calculation and assessment report.
  • QA Executive: Verifies data integrity and compliance to ICH requirements.
  • Department Head: Approves the LOD/LOQ report and method validation package.
See also  Analytical Method Development: SOP for Osmolality Measurement in Sterile Products - V 2.0

4. Accountability

The Department Head of Analytical Method Development is accountable for the implementation and compliance of this SOP across all applicable methods.

5. Procedure

5.1 Definitions

  • LOD: The lowest amount of analyte in a sample which can be detected but not necessarily quantified.
  • LOQ: The lowest amount of analyte in a sample that can be quantitatively determined with suitable precision and accuracy.

5.2 Methods for Determination

  1. LOD and LOQ can be established using:
    • Signal-to-Noise Ratio (S/N)
    • Calibration Curve Approach (Standard Deviation of response and slope)
    • Visual Evaluation
  2. The selection of method shall be documented and justified based on the type of method and sensitivity required.

5.3 Signal-to-Noise Method

  1. Prepare a series of dilute solutions of known concentration near the expected LOD/LOQ.
  2. Inject solutions into HPLC/GC system and measure signal-to-noise ratio.
  3. Acceptance Criteria:

    • LOD: S/N ≥ 3
    • LOQ: S/N ≥ 10
  4. Document results in Annexure-1: S/N LOD-LOQ Log.
See also  Analytical Method Development: SOP for Bioburden Method Development for APIs - V 2.0

5.4 Calibration Curve Method

  1. Prepare at least 6 concentrations of the analyte covering the low concentration range.
  2. Plot the linearity curve and determine:
    • Standard deviation of y-intercepts (σ)
    • Slope of the curve (S)
  3. Calculate:
    • LOD = 3.3 × (σ/S)
    • LOQ = 10 × (σ/S)
  4. Document results in Annexure-2: Calibration-Based LOD/LOQ Log.

5.5 Documentation

  1. All raw data, chromatograms, and calculations must be retained and attached to the method validation report.
  2. Results must be reviewed by a second analyst and authorized by the QA reviewer.

6. Abbreviations

  • SOP: Standard Operating Procedure
  • LOD: Limit of Detection
  • LOQ: Limit of Quantification
  • QA: Quality Assurance
  • S/N: Signal-to-Noise Ratio

7. Documents

  1. S/N LOD-LOQ Log – Annexure-1
  2. Calibration-Based LOD/LOQ Log – Annexure-2
  3. Method Validation Summary Sheet – Annexure-3

8. References

  • ICH Q2(R1): Validation of Analytical Procedures
  • FDA Guidance for Industry: Analytical Procedures and Methods Validation
  • WHO Technical Report Series 996
See also  Analytical Method Development: SOP for Water for Injection (WFI) Quality Testing Method - V 2.0

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name Deepika Joshi Ashwin Rao Sunita Reddy
Designation Analytical Chemist QA Executive Dept. Head
Department AMD QA Analytical Method Development

11. Annexures

Annexure-1: S/N LOD-LOQ Log

Sample ID Concentration (µg/mL) S/N Ratio LOD/LOQ Tested By
LOD-01 0.05 3.2 LOD Deepika Joshi
LOQ-01 0.15 10.4 LOQ Deepika Joshi

Annexure-2: Calibration-Based LOD/LOQ Log

σ (SD of y-intercepts) Slope (S) LOD (µg/mL) LOQ (µg/mL)
0.005 0.085 0.194 0.588

Annexure-3: Method Validation Summary Sheet

Method Name Assay of Paracetamol
LOD Method Used S/N Ratio
LOQ Method Used Calibration Curve
Final LOD 0.05 µg/mL
Final LOQ 0.15 µg/mL
Validated By QA Department

Revision History:

Revision Date Revision No. Details Reason Approved By
21/05/2025 2.0 Updated to include calibration curve method Regulatory Update Sunita Reddy
05/03/2022 1.0 Initial Issue New SOP QA Head
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: Biosimilars: SOP for Harvest Clarification Using Depth Filtration – V 2.0
Next Post: Gel Manufacturing: SOP for Disposal of Expired Gel Materials – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2026 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version